Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XNCR Xencor Inc

已收盘 05-08 16:00:00 EDT

8.79

+0.81

+10.08%

盘后8.79

+0.000.00%

19:10 EDT

最高9.05	最低7.85	成交量134.38万
今开7.85	昨收7.99	日振幅15.03%
总市值6.25亿	流通市值5.65亿	总股本7,115万
成交额1,159万	换手率2.09%	流通股本6,431万
市净率0.92	ROE-35.41%	每股收益-3.58
52周最高27.24	52周最低7.16	市盈率-2.46
股息0.00	股息收益率0.00	ROA-11.48%

北京优虎网络科技有限公司

{"stockData":{"symbol":"XNCR","market":"US","secType":"STK","nameCN":"Xencor Inc","latestPrice":8.79,"timestamp":1746734400000,"preClose":7.985,"halted":0,"volume":1343774,"hourTrading":{"tag":"盘后","latestPrice":8.79,"preClose":8.79,"latestTime":"19:10 EDT","volume":42221,"amount":371109.34,"timestamp":1746745828237},"delay":0,"floatShares":64308014,"shares":71151714,"eps":-3.576467,"marketStatus":"已收盘","change":0.805,"latestTime":"05-08 16:00:00 EDT","open":7.85,"high":9.05,"low":7.85,"amount":11590554.66525,"amplitude":0.150282,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.576467,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746777600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1386046800000,"exchange":"NASDAQ","adjPreClose":7.985,"preHourTrading":{"tag":"盘前","latestPrice":7.89,"preClose":7.985,"latestTime":"09:29 EDT","volume":711,"amount":5642.249994000001,"timestamp":1746710999999},"postHourTrading":{"tag":"盘后","latestPrice":8.79,"preClose":8.79,"latestTime":"19:10 EDT","volume":42221,"amount":371109.34,"timestamp":1746745828237},"volumeRatio":0.940011,"impliedVol":0.8017,"impliedVolPercentile":0.908},"requestUrl":"/m/hq/s/XNCR/tweets","defaultTab":"tweets","newsList":[{"id":"2534151907","title":"巴克莱：维持Xencor(XNCR.US)评级，由减持调整至减持评级, 目标价由22.00美元调整至6.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534151907","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534151907?lang=zh_cn&edition=full","pubTime":"2025-05-09 00:52","pubTimestamp":1746723163,"startTime":"0","endTime":"0","summary":"巴克莱：维持Xencor(XNCR.US)评级，由减持调整至减持评级, 目标价由22.00美元调整至6.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09005250242494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["XNCR"],"gpt_icon":0},{"id":"2533370951","title":"Xencor, Inc.盘中异动 股价大涨5.45%报8.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533370951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533370951?lang=zh_cn&edition=full","pubTime":"2025-05-08 22:34","pubTimestamp":1746714896,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日22时34分，Xencor, Inc.股票出现波动，股价急速拉升5.45%。截至发稿，该股报8.42美元/股，成交量18.3061万股，换手率0.26%，振幅6.32%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为2.88%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508223456aa2c8789&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508223456aa2c8789&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2533215934","title":"Xencor, Inc.盘中异动 早盘急速下挫5.08%报8.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533215934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533215934?lang=zh_cn&edition=full","pubTime":"2025-05-07 22:29","pubTimestamp":1746628184,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日22时29分，Xencor, Inc.股票出现异动，股价快速下跌5.08%。截至发稿，该股报8.03美元/股，成交量21.0432万股，换手率0.30%，振幅6.26%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050722294494ef5cb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050722294494ef5cb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2533637233","title":"Xencor, Inc.盘中异动 早盘股价大跌5.04%报10.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533637233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533637233?lang=zh_cn&edition=full","pubTime":"2025-05-06 22:01","pubTimestamp":1746540068,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日22时01分，Xencor, Inc.股票出现异动，股价快速跳水5.04%。截至发稿，该股报10.18美元/股，成交量3.508万股，换手率0.05%，振幅4.10%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为4.12%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062201089750c5eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505062201089750c5eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","KTTA","BK4139"],"gpt_icon":0},{"id":"2532067029","title":"Xencor, Inc.盘中异动 急速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532067029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532067029?lang=zh_cn&edition=full","pubTime":"2025-05-01 03:14","pubTimestamp":1746040472,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日03时14分，Xencor, Inc.股票出现波动，股价快速上涨5.01%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为1.40%。其相关个股中，Regulus Therapeutics Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Abeona Therapeutics Inc.涨幅较大，Purple Biotech Ltd、Processa Pharmaceuticals, Inc.、Regulus Therapeutics Inc.较为活跃，换手率分别为165.32%、44.52%、38.90%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Abeona Therapeutics Inc.、Xtl生物制药，振幅分别为64.00%、37.52%、36.63%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050103143394e94379&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050103143394e94379&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2530132805","title":"Xencor, Inc.盘中异动 早盘大幅下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530132805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530132805?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:44","pubTimestamp":1745588656,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时44分，Xencor, Inc.股票出现异动，股价大幅下跌5.17%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为1.02%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Jaguar Health, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Azitra Inc、Briacell Therapeutics Corp.、Acrivon Therapeutics, Inc.较为活跃，换手率分别为218.66%、64.05%、42.96%，振幅较大的相关个股有Onconetix, Inc.、Azitra Inc、Jaguar Health, Inc.，振幅分别为25.80%、22.68%、19.48%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425214416a6c81fc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425214416a6c81fc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2529681050","title":"Xencor, Inc.盘中异动 早盘急速上涨5.54%报11.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529681050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529681050?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:32","pubTimestamp":1745415126,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时32分，Xencor, Inc.股票出现异动，股价大幅上涨5.54%。截至发稿，该股报11.24美元/股，成交量1.2367万股，换手率0.02%，振幅2.82%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213207a463f985&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213207a463f985&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2527248494","title":"Xencor, Inc.盘中异动 快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527248494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527248494?lang=zh_cn&edition=full","pubTime":"2025-04-16 02:54","pubTimestamp":1744743277,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日02时54分，Xencor, Inc.股票出现异动，股价快速拉升5.15%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Mural Oncology Plc、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Mural Oncology Plc、Dogwood Therapeutics, Inc.、Metavia Inc.较为活跃，换手率分别为1454.86%、1005.84%、268.02%，振幅较大的相关个股有Skye Bioscience, Inc.、Mural Oncology Plc、Dogwood Therapeutics, Inc.，振幅分别为171.53%、97.08%、91.33%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416025437a6bb926f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416025437a6bb926f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2527848145","title":"Xencor, Inc.盘中异动 股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527848145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527848145?lang=zh_cn&edition=full","pubTime":"2025-04-15 03:41","pubTimestamp":1744659683,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日03时41分，Xencor, Inc.股票出现异动，股价快速拉升5.15%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为2.87%。其相关个股中，天境生物、Immatics N V C/Wts 01/07/2025 、Third Harmonic Bio, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为811.54%、692.31%、346.88%，振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Artelo Biosciences, Inc.、Zyversa Therapeutics, Inc.，振幅分别为78.58%、66.92%、66.29%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415034123a6ba60d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415034123a6ba60d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2526617916","title":"Xencor, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526617916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526617916?lang=zh_cn&edition=full","pubTime":"2025-04-12 03:02","pubTimestamp":1744398135,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日03时02分，Xencor, Inc.股票出现波动，股价急速拉升5.05%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为1.82%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2137.96%、1785.35%、404.52%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.，振幅分别为193.75%、156.27%、77.44%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412030215a4567794&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412030215a4567794&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2517430772","title":"Xencor, Inc.2024财年实现净利润-2.33亿美元，同比减少75.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430772","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517430772?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363251,"startTime":"0","endTime":"0","summary":"3月8日，Xencor, Inc.公布财报，公告显示公司2024财年净利润为-2.33亿美元，同比减少75.19%；其中营业收入为1.10亿美元，同比减少37.14%，每股基本收益为-3.58美元。从资产负债表来看，Xencor, Inc.总负债2.78亿美元，其中短期债务51.46百万美元，资产负债比为3.43，流动比率为0.07。机构评级：截至2025年3月8日，当前有10家机构对Xencor, Inc.目标价做出预测，其中目标均价为30.30美元，其中最低目标价为22.00美元，最高目标价为40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000218a2647f5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000218a2647f5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR"],"gpt_icon":0},{"id":"2516634986","title":"Xencor, Inc.盘中异动 下午盘快速跳水5.05%报14.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634986?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:29","pubTimestamp":1741033747,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时29分，Xencor, Inc.股票出现波动，股价急速下挫5.05%。截至发稿，该股报14.59美元/股，成交量37.7305万股，换手率0.54%，振幅5.63%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4611.46%、215.05%、186.61%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040429079637fc0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040429079637fc0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2516377311","title":"富国银行：维持Xencor(XNCR.US)评级，由增持调整至增持评级, 目标价由37.00美元调整至33.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516377311","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516377311?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:31","pubTimestamp":1740763885,"startTime":"0","endTime":"0","summary":"富国银行：维持Xencor(XNCR.US)评级，由增持调整至增持评级, 目标价由37.00美元调整至33.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01013148469988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["XNCR"],"gpt_icon":0},{"id":"2514385233","title":"Xencor, Inc.盘中异动 快速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385233?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:34","pubTimestamp":1740666888,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时34分，Xencor, Inc.股票出现波动，股价大幅拉升5.01%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Alector, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为429.63%、92.78%、66.03%，振幅较大的相关个股有Channel Therapeutics Corporation、Quoin Pharmaceuticals Ltd、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为16.14%、15.14%、14.83%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223449989510a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223449989510a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"1168323239","title":"Xencor第四季度每股亏损$(0.62)好于预期$(0.78)，销售额$52.79M超预期$19.48M","url":"https://stock-news.laohu8.com/highlight/detail?id=1168323239","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168323239?lang=zh_cn&edition=full","pubTime":"2025-02-27 21:25","pubTimestamp":1740662707,"startTime":"0","endTime":"0","summary":"Xencor 报告的季度每股亏损为$，好于分析师预期的$，超出20.51%。相比去年同期销售额$50.97M，本季度销售额增长了3.59%。以上内容来自Benzinga Earnings专栏，原文如下：Xencor  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 20.51 percent. This is a 44.19 percent decrease over losses of $ per share from the same period last year. The company reported quarterly sales of $52.79 million which beat the analyst consensus estimate of $19.48 million by 171.05 percent. This is a 3.59 percent increase over sales of $50.97 millio","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Xencor第四季度每股亏损$(0.62)好于预期$(0.78)，销售额$52.79M超预期$19.48M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XNCR"],"gpt_icon":0},{"id":"2506894173","title":"Xencor, Inc.盘中异动 股价大跌5.08%报19.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506894173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506894173?lang=zh_cn&edition=full","pubTime":"2025-01-25 03:09","pubTimestamp":1737745755,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日03时09分，Xencor, Inc.股票出现异动，股价急速下挫5.08%。截至发稿，该股报19.42美元/股，成交量14.6523万股，换手率0.21%，振幅5.13%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Neuphoria Therapeutics Inc.、Evaxion Biotech As、Pmgc Holdings Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4300.35%、2362.24%、1715.58%，振幅较大的相关个股有Neuphoria Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 、Evaxion Biotech As，振幅分别为261.67%、220.61%、137.09%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125030916abb78b57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125030916abb78b57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2505789468","title":"Xencor, Inc.盘中异动 快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505789468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505789468?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:10","pubTimestamp":1737490210,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时10分，Xencor, Inc.股票出现异动，股价快速上涨5.15%。截至发稿，该股报20.23美元/股，成交量26.2472万股，换手率0.38%，振幅5.07%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为1.87%。其相关个股中，Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Channel Therapeutics Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为1052.00%、526.21%、190.70%，振幅较大的相关个股有Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为96.32%、69.49%、50.37%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122041010abb38e37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122041010abb38e37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2503251886","title":"Xencor, Inc.盘中异动 早盘股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503251886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503251886?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:23","pubTimestamp":1736954594,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时23分，Xencor, Inc.股票出现波动，股价急速上涨5.39%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为1.39%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Os Therapies Incorporated较为活跃，换手率分别为205.05%、141.51%、78.00%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Os Therapies Incorporated、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为68.03%、61.30%、54.40%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115232314a2230ba2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115232314a2230ba2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2503635701","title":"Xencor, Inc.盘中异动 下午盘快速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503635701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503635701?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:05","pubTimestamp":1736885109,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时05分，Xencor, Inc.股票出现波动，股价大幅下挫5.13%。截至发稿，该股报19.22美元/股，成交量31.5518万股，换手率0.45%，振幅6.12%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115040509a221fdb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115040509a221fdb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2502062895","title":"Xencor, Inc.盘中异动 急速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502062895","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502062895?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:03","pubTimestamp":1736521434,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时03分，Xencor, Inc.股票出现波动，股价急速下跌5.04%。截至发稿，该股报22.25美元/股，成交量7.3492万股，换手率0.11%，振幅2.07%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为1.06%。其相关个股中，Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1089.24%、314.58%、193.47%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.，振幅分别为72.56%、41.78%、37.29%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011023035595ff758c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011023035595ff758c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xencor.com","stockEarnings":[{"period":"1week","weight":-0.2754},{"period":"1month","weight":-0.046},{"period":"3month","weight":-0.5371},{"period":"6month","weight":-0.6619},{"period":"1year","weight":-0.6706},{"period":"ytd","weight":-0.6525}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.1126},{"period":"3month","weight":-0.0745},{"period":"6month","weight":-0.0619},{"period":"1year","weight":0.0851},{"period":"ytd","weight":-0.0425}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xencor, Inc.在加利福尼亚州成立于1997年8月，2004年9月在特拉华州重组。该公司是一家临床阶段的生物制药公司，专注于发现和开发工程化的单克隆抗体和细胞因子疗法，以治疗癌症和自身免疫性疾病患者，这些患者的医疗需求尚未得到满足。该公司利用蛋白质工程能力来增加对蛋白质结构和相互作用的理解，并设计新技术和具有改进特性的XmAb候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.048245},{"month":2,"riseRate":0.583333,"avgChangeRate":0.045235},{"month":3,"riseRate":0.25,"avgChangeRate":-0.051542},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.037771},{"month":5,"riseRate":0.583333,"avgChangeRate":0.018141},{"month":6,"riseRate":0.636364,"avgChangeRate":0.097167},{"month":7,"riseRate":0.545455,"avgChangeRate":-0.00398},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.014858},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.022096},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.016825},{"month":11,"riseRate":0.909091,"avgChangeRate":0.146604},{"month":12,"riseRate":0.545455,"avgChangeRate":0.016646}],"exchange":"NASDAQ","name":"Xencor Inc","nameEN":"Xencor"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xencor Inc(XNCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xencor Inc,XNCR,Xencor Inc股票,Xencor Inc股票老虎,Xencor Inc股票老虎国际,Xencor Inc行情,Xencor Inc股票行情,Xencor Inc股价,Xencor Inc股市,Xencor Inc股票价格,Xencor Inc股票交易,Xencor Inc股票购买,Xencor Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xencor Inc(XNCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}